Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc (VIR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vir Biotechnology Inc 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 USA

P: 415-906-4324

Description:

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,711,681
Shares Outstanding, K 130,880
Annual Sales, $ 76,370 K
Annual Net Income, $ -298,670 K
Last Quarter Sales, $ 103,620 K
Last Quarter Net Income, $ 110,430 K
60-Month Beta -1.44
% of Insider Shareholders 37.20%
% of Institutional Shareholders 75.41%
Float, K 82,193
% Float 62.80%

Growth:

1-Year Return 26.72%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.85 on 11/04/21
Next Earnings Date N/A
Earnings Per Share ttm -0.87
EPS Growth vs. Prev Qtr 78.26%
EPS Growth vs. Prev Year 222.39%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VIR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth 2.86
Return-on-Equity % -13.73%
Return-on-Assets % -9.47%
Profit Margin % -391.08
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 54.88
Price/Cash Flow N/A
Price/Book 4.77
Book Value/Share 6.71
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar